November 2025 in “Scholarly Commons (Embry–Riddle Aeronautical University)” This review discusses how urban air pollutants may influence the regulation of JAK3 signaling in alopecia areata and reports no new experimental results; the authors integrate existing data to map potential pathways and biomarkers.
July 2025 in “Journal of Investigative Dermatology” Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.
February 2025 in “PubMed” In this study, researchers evaluated CS12192, a selective JAK3 inhibitor, in an alopecia areata mouse model and found it reversed hair growth inhibition comparably to baricitinib, with better safety and similar immune-modulating mechanisms.
October 2021 in “International Journal of Dermatology” This article poses the question of whether Janus kinase (JAK) inhibitors are beneficial for treating androgenic alopecia, but it does not provide results or conclusions from any study.
4 citations
,
February 2024 in “Anais Brasileiros de Dermatologia”
3 citations
,
August 2025 in “Frontiers in Pharmacology” Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.
3 citations
,
July 2024 in “Archives of Dermatological Research” This study found that oral dexamethasone and DPCP were more effective for treating severe alopecia areata compared to oral ritlecitinib and baricitinib, but oral ritlecitinib had better safety outcomes.
January 2016 in “Hair transplant forum international” Topical JAK inhibitors may help treat hair loss.
November 2020 in “Journal of The American Academy of Dermatology” This case report highlights that patients with long-standing alopecia areata treated with oral JAK inhibitors experienced unexpected hair regrowth patterns resembling male-pattern baldness.
1 citations
,
December 2023 in “Journal of the European Academy of Dermatology and Venereology” 1 citations
,
January 2004 in “Wieś Jutra” This study suggests that finasteride may inhibit testosterone-induced expression of TGF-beta1 and type I procollagen, potentially explaining its role in preventing perifollicular fibrosis in androgenetic alopecia.
April 2026 in “Our Dermatology Online”
222 citations
,
September 2016 in “JCI insight” This research overview highlights that although JAK inhibitors show promise as potential treatments for alopecia areata based on recent insights into the disease mechanism, their efficacy has not yet been thoroughly evaluated in a systematic manner.
November 2025 in “Journal of Investigative Dermatology” August 2025 in “Acta Dermato Venereologica”
This study found that additive discourse markers were the most frequently used type in a sampled news article from The Jakarta Post.
21 citations
,
May 2024 in “Journal of Ethnopharmacology” 1 citations
,
April 2024 in “Journal of Dermatological Science” January 2026 in “Cytokine”
January 2024 in “Wiadomości Lekarskie” This study highlights the transformation in aortic aneurysm treatment over the last 30 years, noting the shift from open surgery to endovascular methods, which reduce surgical risks and improve outcomes.
January 2026 in “MitraMas Jurnal Pengabdian dan Pemberdayaan Masyarakat” This study found that educational interventions at SMK Farmasi Penabur, Jakarta, significantly improved students' knowledge about proper hair care practices, with a notable increase in the percentage of participants with very high knowledge levels after the program.
1 citations
,
October 2025 in “International Journal of Molecular Sciences” This narrative review highlights the potential of naturally occurring compounds to target specific molecular pathways and overcome resistance in advanced and recurrent papillary thyroid cancer, offering new therapeutic possibilities beyond traditional treatments like surgery and lifelong hormone replacement.
1 citations
,
March 2022 in “Dermatology Reports” This study found that at Dr. Cipto Mangunkusumo National General Hospital in Jakarta, alopecia areata was the most prevalent hair disorder, followed by alopecia androgenetic and telogen effluvium, each with distinct socio-demographic profiles.
July 2026 in “Journal of the American Academy of Dermatology”
October 2023 in “Al-Kauniyah” In this study of gibbons at the Tegal Alur Animal Rescue Center, researchers found that while the feeding schedule met natural requirements, the gibbons' body weights were lower compared to their counterparts in the wild, and some exhibited hair loss and depigmentation.
July 2022 in “Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)” This study observed that late seniors and men are more susceptible to severe COVID-19 infections, with diabetes identified as the most common comorbidity linked to severe symptoms and lower lymphocyte levels.
July 2022 in “Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)” This study observed that in COVID-19 patients at Zahirah General Hospital, older men with diabetes were more prone to severe symptoms and had lower lymphocyte levels.
July 2026 in “Journal of the American Academy of Dermatology”
September 2014 in “Aktuelle Dermatologie” This symposium review highlights past, present, and future developments in skin research, celebrating the work of Prof. Johanna Brandner and Dr. Peter Arne Gerber, without reporting new clinical results.